Mulakan
ChristopherCarrollSmith

Pharmaceuticals showing strength this earnings season

Panjang
Direxion Daily S&P Biotech Bull 3X Shares (AMEX:LABU)  
ChristopherCarrollSmith  
AMEX:LABU   Direxion Daily S&P Biotech Bull 3X Shares
Fundamental Analysis Earnings pharmaceuticals
7
0
fundamental earnings pharmaceuticals
It's been a banner quarter for large-cap pharmaceutical companies. We've had earnings beats and guidance upgrades from GlaxoSmithKline, Biogen, Bristol-Myers Squibb, Merck, Celgene, and Procter & Gamble. More earnings beats may be coming, with Amgen reporting today after market and Amarin tomorrow. In my opinion, the whole sector is set to surge, and the leveraged Direxion Biotech Bull ETF could be a very strong play this quarter if you can find a good entry point.

Idea Berkaitan

ChristopherCarrollSmith
LABU - watch the volume and trend line
Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.